Coral Laboratories approves dividend and Coral Laboratories stock yields 0.35 percent

Published on 10/14/2026 at 01:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

June 2026 revenue rose 57.30 percent year over year. For Coral Laboratories stock this means net profit reached INR 53.9 million.

Dividend and operating figures

Coral Laboratories approved a final dividend of INR 2.00 per share at its September 29, 2026 AGM.
Revenue reached INR 296.2 million in the June 2026 quarter, up 57.30 percent year over year.
Coral Laboratories reported net profit of INR 53.9 million for the June 2026 quarter.

Coral, INE683E01017, Illustration mit AI erstellt.

Coral Laboratories (INE683E01017) approved a final dividend of INR 2.00 per share at its 44th annual general meeting on September 29, 2026, while the stock's dividend yield stood at 0.35 percent on October 9, 2026. Screener reported the AGM approval, and StockFin.ai listed the yield.

June revenue grows 57.30 percent

Coral Laboratories recorded revenue of INR 296.2 million in the June 2026 quarter, representing 57.30 percent growth from the same quarter a year earlier. Net profit reached INR 53.9 million, up 110.50 percent year over year, according to StockFin.ai.

The operating profit margin was 16.27 percent in the June 2026 quarter, compared with 9.13 percent in the June 2025 quarter. Operating profit therefore increased alongside the higher sales base, although the margin remained below the 25.96 percent reported for the September 2025 quarter.

Three dated corporate milestones

On May 30, 2026, Coral Laboratories recommended the INR 2.00 per-share final dividend for fiscal 2025-26, according to ALFA Finder. On August 14, 2026, the company reported June-quarter revenue of INR 296.2 million and net profit of INR 53.9 million in the same filing overview.

On September 29, 2026, shareholders approved the audited financial statements, final dividend and director reappointments at the 44th AGM, as documented by Screener. The sequence links the latest corporate event to both the payout and the June operating figures.

What does the payout add?

The dividend gives the company story a shareholder-return component alongside the quarterly growth figures. StockFin.ai listed market capitalization at INR 2.0 billion and promoter ownership at 71.51 percent on October 9, 2026, providing two dated valuation and ownership reference points for the small pharmaceutical manufacturer.

Pharmaceutical operations remain central

Coral Laboratories manufactures and exports pharmaceutical formulations, including tablets, capsules, liquids and topical products, with a focus on generic medicines and emerging markets, according to Screener. The company is listed on the BSE under code 524506 and operates in the pharmaceuticals and biotechnology industry.

Corporate facts and trading context

The dated operating record combines INR 296.2 million of June 2026 revenue, INR 53.9 million of net profit and the INR 2.00 dividend approved in September 2026. Those figures give Coral Laboratories stock a concrete earnings and payout profile for investors assessing the company after the AGM.